You are here: vision-research.eu » News » Newsdetails: Encapsulated Cell Therapy Technology show benefit

Health

Encapsulated Cell Therapy Technology show benefit

September 12, 2017

Phase II results from encapsulated cell therapy technology show benefit in the treatment of patients with macular telangiectasia 2

Results from a Phase II multicentre randomised trial, which had enrolled 67 patients, with macular telangiectasia 2, has reported meeting its primary endpoint, defined as a change in the ellipsoid zone from baseline to month 24, measured by Spectral Domain Optical Coherence Tomography (SD-OCT).


Missing some information on vision-research.eu?

* mandatory field